Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study.

Guler, Sabina Anna; Hur, Seo Am; Stickland, Michael K; Brun, Patrick; Bovet, Luc; Holland, Anne E; Bondarenko, Janet; Hambly, Nathan; Wald, Joshua; Makhdami, Nima; Kreuter, Michael; Gloeckl, Rainer; Jarosch, Inga; Tan, Benjamin; Johannson, Kerri A; McBride, S Ainslie; De Boer, Kaissa; Sandoz, Jacqueline S; Sun, Kelly; Assayag, Deborah; ... (2022). Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study. Thorax, 77(6), pp. 589-595. BMJ Publishing Group 10.1136/thoraxjnl-2021-217361

Text Guler_Sabina_Survival_after_PRinILD_Guler_Thorax2021.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB)

BACKGROUND

The impact of pulmonary rehabilitation (PR) on survival in patients with fibrotic interstitial lung disease (ILD) is unknown. Given the challenges conducting a large randomised controlled trial, we aimed to determine whether improvement in 6-minute walk distance (6MWD) was associated with better survival.

METHODS

This retrospective, international cohort study included patients with fibrotic ILD participating in either inpatient or outpatient PR at 12 sites in 5 countries. Multivariable models were used to estimate the association between change in 6MWD and time to death or lung transplantation accounting for clustering by centre and other confounders.

RESULTS

701 participants (445 men and 256 women) with fibrotic ILD were included. The mean±SD ages of the 196 inpatients and 505 outpatients were 70±11 and 69±12 years, respectively. Baseline/changes in 6MWD were 262±128/55±83 m for inpatients and 358±125/34±65 m for outpatients. Improvement in 6MWD during PR was associated with lower hazard rates for death or lung transplant on adjusted analysis for both inpatient (HR per 10 m 0.94, 95% CI 0.91 to 0.97, p<0.001) and outpatient PR (HR 0.97, 95% CI 0.95 to 1.00, p=0.042). Participation in ≥80% of planned outpatient PR sessions was associated with a 33% lower risk of death (95% CI 0.49% to 0.92%).

CONCLUSIONS

Patients with fibrotic ILD who improved physical performance during PR had better survival compared with those who did not improve performance. Confirmation of these hypothesis-generating findings in a randomised controlled trial would be required to definitely change clinical practice, and would further support efforts to improve availability of PR for patients with fibrotic ILD.

Interest & Impact

Downloads

4 since deposited on 21 Sep 2021
2 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item